Dombret H - Search Results

1

Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment.

Fenwarth L, Fournier E, Cheok M, Boyer T, Gonzales F, Castaigne S, Boissel N, Lambert J, Dombret H, Preudhomme C, Duployez N. Fenwarth L, et al. Among authors: dombret h. Int J Mol Sci. 2020 Aug 6;21(16):5626. doi: 10.3390/ijms21165626. Int J Mol Sci. 2020. PMID: 32781546 Free PMC article. Review.

2

All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases.

Fenaux P, Castaigne S, Dombret H, Archimbaud E, Duarte M, Morel P, Lamy T, Tilly H, Guerci A, Maloisel F, et al. Fenaux P, et al. Among authors: dombret h. Blood. 1992 Nov 1;80(9):2176-81. Blood. 1992. PMID: 1421389 Free article. Clinical Trial.

3

Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.

Dombret H, Sutton L, Duarte M, Daniel MT, Leblond V, Castaigne S, Degos L. Dombret H, et al. Leukemia. 1992 Dec;6(12):1237-42. Leukemia. 1992. PMID: 1453767

4

All trans retinoic acid treatment for patients with acute promyelocytic leukemia.

Fenaux P, Castaigne S, Chomienne C, Dombret H, Degos L. Fenaux P, et al. Among authors: dombret h. Leukemia. 1992;6 Suppl 1:64-6. Leukemia. 1992. PMID: 1548938 Review. No abstract available.

5

All trans retinoic acid in acute promyelocytic leukemia.

Degos L, Castaigne S, Fenaux P, Daniel MT, Dombret H, Chomienne C. Degos L, et al. Among authors: dombret h. Nouv Rev Fr Hematol (1978). 1991;33(2):183-5. Nouv Rev Fr Hematol (1978). 1991. PMID: 1766850 Review. No abstract available.

6

In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy.

Dombret H, Scrobohaci ML, Daniel MT, Micléa JM, Castaigne S, Chomienne C, Fenaux P, Degos L. Dombret H, et al. Leukemia. 1995 Jan;9(1):19-24. Leukemia. 1995. PMID: 7531260

7

Changes in microrheology of acute promyelocytic leukemia cells during all-trans retinoic acid (ATRA) differentiation therapy: a mechanism for ATRA-induced hyperleukocytosis?

Dombret H, Geiger S, Daniel MT, Glaisner S, Micléa JM, Castaigne S, Merle-Beral H, Lacombe C, Chomienne C, Degos L. Dombret H, et al. Leukemia. 1995 Sep;9(9):1473-7. Leukemia. 1995. PMID: 7658714

8

Unexpected high incidence of intracranial subdural haematoma during intensive chemotherapy for acute myeloid leukaemia with a monoblastic component.

Jourdan E, Dombret H, Glaisner S, Micléa JM, Castaigne S, Degos L. Jourdan E, et al. Among authors: dombret h. Br J Haematol. 1995 Mar;89(3):527-30. doi: 10.1111/j.1365-2141.1995.tb08358.x. Br J Haematol. 1995. PMID: 7734350 Clinical Trial.

9

All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia.

Degos L, Dombret H, Chomienne C, Daniel MT, Micléa JM, Chastang C, Castaigne S, Fenaux P. Degos L, et al. Among authors: dombret h. Blood. 1995 May 15;85(10):2643-53. Blood. 1995. PMID: 7742522 Free article. Review. No abstract available.

10

Induction treatment of acute promyelocytic leukemia using all-trans retinoic acid. Controversies about dosage, advantages and side-effect management.

Dombret H, Castaigne S, Fenaux P, Chomienne C, Degos L. Dombret H, et al. Leukemia. 1994;8 Suppl 3:S73-5. Leukemia. 1994. PMID: 7808030 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

440 results

Search Page